Patents by Inventor Ramiro Garzon

Ramiro Garzon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MicroRNA Fingerprints During Human Megakaryocytopoiesis
    Publication number: 20120329053
    Abstract: Described herein is a method of decreasing expression of HOXA1 in a subject having a cancer and/or myeloproliferative disorder associated with overexpression of a HOXA1 gene product where an effective amount of at least one miR-10a gene product or an isolated variant or biologically-active fragment thereof is administered to the subject sufficient to decrease expression of the HOXA1 gene product in the subject.
    Type: Application
    Filed: August 27, 2012
    Publication date: December 27, 2012
    Inventors: Carlo M. Croce, Ramiro Garzon, George A. Calin
  • MicroRNA Fingerprints During Human Megakaryocytopoiesis
    Publication number: 20120329859
    Abstract: Described herein is a method of decreasing expression of MAFB in a subject having a cancer and/or myeloproliferative disorder associated with overexpression of a MAFB gene product where an effective amount of at least one miR-130a gene product or an isolated variant or biologically-active fragment thereof is administered to the subject sufficient to decrease expression of the MAFB gene product in the subject.
    Type: Application
    Filed: August 27, 2012
    Publication date: December 27, 2012
    Inventors: Carlo M. Croce, Ramiro Garzon, George A. Calin
  • MicroRNA Fingerprints During Human Megakaryocytopoiesis
    Publication number: 20120322859
    Abstract: Described herein is a method of decreasing expression of HOXA1 in a subject having a cancer and/or myeloproliferative disorder associated with overexpression of a HOXA1 gene product where an effective amount of at least one miR-10a gene product or an isolated variant or biologically-active fragment thereof is administered to the subject sufficient to decrease expression of the HOXA1 gene product in the subject.
    Type: Application
    Filed: August 27, 2012
    Publication date: December 20, 2012
    Inventors: Carlo M. Croce, Ramiro Garzon, George A. Calin
  • MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS
    Publication number: 20110287970
    Abstract: The present invention provides novel methods and compositions for the diagnosis, prognosis and treatment of cancer and myeloproliferative disorders. The invention also provides methods of identifying anti-cancer agents.
    Type: Application
    Filed: June 27, 2011
    Publication date: November 24, 2011
    Inventors: Carlo M. Croce, Ramiro Garzon, George A. Calin
  • MicroRNA fingerprints during human megakaryocytopoiesis
    Patent number: 7985584
    Abstract: The present invention provides novel methods and compositions for the diagnosis, prognosis and treatment of cancer and myeloproliferative disorders. The invention also provides methods of identifying anti-cancer agents.
    Type: Grant
    Filed: March 19, 2007
    Date of Patent: July 26, 2011
    Assignee: The Ohio State University Research Foundation
    Inventors: Carlo M. Croce, Ramiro Garzon, George A. Calin
  • Hybridization Quantitation Method for Modified Micro-RNA and -DNA Based Oligonucleotides
    Publication number: 20110027798
    Abstract: Described herein is a method for the qualitative and/or quantitative determination of an analyte in a test sample which includes base pairing at least one oligonucleotide to a capture template having an overhang; and, hybridizing with a detection probe.
    Type: Application
    Filed: March 31, 2009
    Publication date: February 3, 2011
    Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Kenneth K. Chan, Zhongfa Liu, Zhiliang Xie, Guido Marcucci, John C. Byrd, Natarajan Muthusamy, Ramiro Garzon, Shujun Lui
  • MicroRNA Fingerprints During Human Megakaryocytopoiesis
    Publication number: 20090209450
    Abstract: The present invention provides novel methods and compositions for the diagnosis, prognosis and treatment of cancer and myeloproliferative disorders. The invention also provides methods of identifying anti-cancer agents.
    Type: Application
    Filed: March 19, 2007
    Publication date: August 20, 2009
    Applicant: THE OHIO STATE UNIVERSITY
    Inventors: Carlo M. Croce, Ramiro Garzon, George A. Calin